NHS Comes Across Funding Problems with Developing of Stem Cells
The promise of stem-cell research to come up with new therapies for stipulations such as diabetes, Parkinson’s disease, heart condition and paralysis is being arrested by financial backing troubles and the NHS’s institutionalized culture, a report indicates. While British academic stem-cell science is internationally competitive, a lack of commercialized investment funds and NHS support is blocking its prospective to aid patients and produce profits, scientists at the University of Nottingham have said.
Although the British Government has distinguished regenerative medicine as a national priority and the United States has lifted its ban on stem-cell therapy, urgent public policy action is needed if it is to become a reality.
Britain has long punched above its weight in basic medical science, from the discovery of penicillin to the latest advances in stem cell research.
It has been much less good at translating that research first into products, whether drugs or devices, then into the rapid adoption of effective treatments at the bedside, and then getting the best ways of treating patients – of preventing or slowing disease – out into the community.
Stem cells are cells found in most, if not all, multi-cellular organisms. They are characterized by the ability to renew themselves through mitotic cell division and differentiating into a diverse range of specialized cell types. Research in the stem cell field grew out of findings by Canadian scientists Ernest A. McCulloch and James E. Till in the 1960s. The two broad types of mammalian stem cells are: embryonic stem cells that are isolated from the inner cell mass of blastocysts, and adult stem cells that are found in adult tissues. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing specialized cells, but also maintain the normal turnover of regenerative organs, such as blood, skin or intestinal tissues.
Comments are currently closed.